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DIMETHYLSULFOXIDE AND 2-PYRROLIDONE

ABSTRACT OF THESIS

This research utilizing full thickness human abdominal
~skin

was designed to assess the in vitro percutaneous pene-

tration of benzocaine by 1-dodecylazacycloheptan-2-one
(Azone) , dimethylsulfoxide (DMSO) and 2-pyrrolidone (2-P)
under conditions of constant thermodynamic activity in the
vehicle.

The solubilities of benzocaine in Azone and

80/20, 60/40 and 40/60 V/V DMSO/water systems were found to
be 254.17, 533.00, 68.60 and 2.51 mg/ml respectively.

All

three adjuvants demonstrated a significant but concentration-dependent enhancement of benzocaine penetration.

On

the basis of comparative analysis of the steady-state
fluxes, Azone was most effective at the level of 5% V/V
when drug concentration was twice the saturation solubility
_jn the 20/80 PG/water gel.

At higher Azone levels, any

penetration enhancement effects were strongly negated by a
corresponding decrease in skin/vehicle partitioning.

Azone

appeared to enhance penetration of benzocaine molecules by
directly reducing the barrier function of the stratum

----

corneum.

DMSO-induced enhancement of benzocaine penetra;=;----

fj

tion was observed over 40/80% V/V DMSO.

Pretreatment

studies strongly suggested that enhancement by DMSO is due
to a significant but temporary effect on the epidermal
barrier.

The moderate enhancement of benzocaine penetra-

tion shown by 80% 2-P in water could be due to a decrease
in diffusional resistance of stratum corneum brought on by
a slow interaction between the stratum corneum and 2-P.
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INTRODUCTION
The process of transdermal drug absorption offers a
great challenge to research workers in the fields of
pharmacy and dermatology.

The skin is one of the most

impenetrable tissues of the body, for it functions as a
barrier against invasion by microorganisms and viruses and
simultaneously limits the escape of physiologically essential components, such as water, from the body.

For passage

through the skin, the penetrating molecule must move first
through the stratum corneum, then into the viable epidermis,
the papillary layers of the dermis, and the capillary walls
into the blood stream.

The viable tissue layers and the

capillaries are relatively permeable and the peripheral
circulation sufficiently rapid so that diffusion through
the stratum corneum itself is rate limiting for the great
majority of substances (1,2).
The stratum corneum consists of dense, highly compressed, partially desiccated cells.

This layer has

regions rich in protein separated by a lipoidal framework.
The stratum corneum is formed and continuously replenished
by slow migration of cells from the germinative basal layer
of the epidermis.

Studies have shown that this layer is

constantly regenerated about every two weeks in the mature
adult (3).

An electron micrograph of a highly magnified
l

2

portion of the interior of a stratum corneum cell by Brady
showed that this cell is filled with keratin filaments
0

60-80 A

in diameter, distributed in an amorphous matrix of

mainly lipid and non-fibrous protein.

The conversion of

viable epidermal cells into dried, compact, keratincontaining stratum corneum cells is the crucial event in
the continuously developing epidermis that largely determines the low permeability of the skin.

The filament-

matrix ultrastructure of the intracellular keratin appears
to play a role in the mechanism of diffusion, particularly
in accounting for the selective permeability of polar and
nonpolar molecules.
The mathematical expressions used to describe drug
penetration through skin (4) are based upon the knowledge
that passive diffusion is the predominant mechanism for
penetration through human epidermis.

Hence, Fick's law is

generally applied to describe this process.

Equation 1

describes membrane-limited transport under steady-state
conditions:
D.P.,6C
J

= --------

(Eq. 1)

h

The flux, J, represents the amount of drug passing through
the membrane system per unit area per unit time, D is the
diffusion coefficient within the membrane,

.6 C is the dif-

ference in concentration across the membrane, h is membrane
thickness and P is the membrane/vehicle partition coefficient.

3

The equation allows one to identify the factors that may
be manipulated so as to control percutaneous absorption,
namely the concentration and the partition coefficient
of the penetrant.

Although membrane thickness may remain

constant at a given site, each penetrant may encounter a
different type of barrier and the efficiency of the process
of penetration may be subject to the physical-chemical
properties of both penetrant molecules and those surrounding
the passage (5,6,7).
Percutaneous absorption of local anesthetic agents
has been the subject oa a number of reports

(8,9,10).

Benzocaine (ethyl aminobenzoate) is one of the most widely
used local anesthetics in nonprescription products intended
for relief of itch and pain.

It has been reported (11)

that local anesthetics in general are very poorly absorbed
from the intact skin, but pass into the blood only if the
skin is abraded or burned.

This lack of efficacy of many

nonprescription products in blocking the sensations of itch,
burning and pain has also been supported by other in vivo
studies of local anesthetics on intact and sunburned skin
(12).

Diffusion through the stratum corneum is the rate-

limiting step in benzocaine transport and this accounts
for the reported lack of efficacy of many nonprescription
products.
The role of a vehicle in the transport of drugs into
and through the skin is of fundamental importance for the

4

rational development of topical formulations.

The physical-

chemical characteristics of the components of the vehicle
are a major consideration in the selection of the vehicle.
Substances may be more rapidly released from vehicles
having a low affinity for the penetrant.

Vehicles with

relatively low solvent power for incorporated compounds may
induce more rapid penetration (13).

In general, a compound

must be at least partially soluble in its vehicle so that
it can be readily released into the skin.

High solubility

may result in preferential retention of the drug in the
vehicle.
i-

The physical properties of the components of the

vehicle are also important in the degree of occlusion they
provide leading to water retention in the stratum corneum
layer.
A general approach towards affecting the topical bioavailability of drugs is to incorporate adjuvants which may
either favor a high drug concentration in the stratum
corneum or directly or indirectly affect the barrier
function of the skin (14,15,16).
There are many formulations or substances which, when
applied to the skin, can alter its suppleness and permeability properties which, in turn, depend to a large extent
on the state of the stratum corneum.

Of major interest are

those substances which have a mild or even a reversible
effect on the tissue.

With these substances it may be

possible to alter temporarily the properties of the skin

;=;---~--
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to promote effective drug delivery for both local and/or

r=I---,-~

systemic effect.
Both ionic and nonionic surfactants have been investigated as adjuvants in dermatologic preparations for the
purpose of enhancing the drug solubility and/or lowering
the resistance to drug penetration without much success.
For example, in a recent study of the effect of nonionic
surfactants on benzocaine penetration through hairless
mouse skin, Dalvi and Zatz

(17) found that polyoxyethylene

nonylphenol, a nonionic surfactant, produces a concentrationdependent increase in benzocaine solubility in water.

The

in vitro skin penetration flux, however, was found to be
dependent only on the free benzocaine concentration in
solution rather than total drug concentration in solution
due to micellar entrapment.
Dimethylsulfoxide (DMSO), a polar, relatively nontoxic
organic solvent, has been shown by many investigators to be
an effective vehicle for increasing skin penetration (18,19,
20,21).

Stoughton and Fritsch (18) have presented conclu-

sive evidence to show that DMSO promotes the cutaneous
penetration, in vivo, of the following substances:

(a)

vasoconstrictor, naphazoline (Privine) hydrochloride;

a

(b) an

antiperspirant, hexopyrronium bromide; and (c) a corticosteroid, fluocinolone acetonide; and in vitro, hexopyrronium
chloride and cortisol.

It has also been shown that DMSO

enhances the penetration of water.

An approximately 20-fold

=
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increase in the water transpiration rate occurs in vivo
as compared with a 50-fold increase in water permeation
through excised skin (2).

DMSO lowers the skin's resistance

to drug permeation but the specific mechanism is not fully
understood.

Kligman (2) has shown that the enhanced pene-

tration offered by DMSO was largely reversible and little
permanent damage to the stratum corneum occurred when it was
removed and the tissue rehydrated.

The application of

DMSO to a biological membrane, such as the skin, effects
a nonselective increase in tissue permeability which is not
unique to DMSO but can be demonstrated, in varying degrees,
by many other hypertonic solutions.

In addition, there is

a more specific property of DMSO which facilitates the
movement of DMSO (and compounds which it has dissolved)
across the skin and this appears to be the result of an
increase in the size of passive flux channels through the
membrane (19).

This phenomenon may explain why compounds

which are not well absorbed percutaneously from traditional
vehicles may exhibit a dramatic increase in penetration
when dissolved in DMSO (20).
Azone (1-dodecylazacycloheptan-2-one) has recently
been shown to enhance the biologic activity of various
topically active agents such as antibiotics and antifungals, glucocorticoids and antipsoriatic agents (22,
23).

It is a colorless and relatively odorless compound

that is non-irritating even when applied undiluted to the

7

human skin surface ..

The penetration-enhancing effect of
~

-----
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Azone was observed with concentrations as low as 1%, which
is much lower than that required with other enhancers, such
as urea, DMSO and N,N-dimethylformamide.

In addition,

A7.one caused practically no irritation t'J human skin even
at concentraticns of more

~han

50%.

In light of these

advantages, this substance has aroused considerable interest as a drug penetration enhancer for topical pharmaceutical formulations intended for both local and systemic
effects.
Percutaneous penetration of both hydrophobic and
hydrophilic molecules is enhanced with Azone, although
more dramatic enhancements are usually seen with hydrophilic
drugs.

Stoughton (22) has shown that Azone significantly

enhances the penetration of both anthracene, a hydrophobic
compound, and 8-bromocyclic adenylic acid, a strongly
hydrophilic compound.

At low concentrations of anthracene,

no penetration was observed without Azone and good penetration was observed with Azone.

As the concentration of

anthracene was raised, the effect of Azone was reduced
until high concentrations of the drug showed little or no
enhancement.

Stoughton explained the foregoing result on

the basis of the fact that a highly hydrophobic agent, when
present in high concentrations, can penetrate the skin well
enough so that it prevents Azone from acting to provide
any additional effect.

Examination of the effect of Azone

8

on 8-bromocyclic adenylic acid revealed that the steady-

r, - ~

state rate of penetration of this compound through hairless
mouse skin in vitro was enhanced 12-fold with 1% Azone
relative to control.

The precise mechanism is unknown, but

it has been postulated that Azone alters the lipid and
protein structures of the skin.

Radioactive studies have

shown that Azone is bound in the epidermis and corium and
that relatively little is released from the skin.
Recently, 2-pyrrolidone has been investigated for
potential skin penetration-enhancing properties by Barry
and Southwell (24).
in vitro

~or

They measured the steady-state fluxes

polar methanol, non-polar octanol, and an

intermediate compound, caffeine, using human stratum
corneum, and determined partition, permeability and the
apparent diffusion coefficient.

It was concluded that

2-pyrrolidone enhances permeation through the polar route
of the skin by increasing the diffusivity, and reduces
passage through the nonpolar route by decreasing diffusivity
and partitioning.

Stoughton (25) and coworkers combined

2-pyrrolidone with clindamycin in the treatment of acne
vulgaris and suggested that the compound aided penetration
of clindamycin into the comedo.

In a study, five patients

used clindamycin phosphate in 2-pyrrolidone for periods
from 7 to 19 weeks.

All five had complete suppression of

growth of the acne organism in open comedones.

-
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Low molecular weight polyols are used extensively in
cosmetic and dermatologic practice.

Propylene glycol in

particular has been shown to increase the aqueous solubility of many drugs and also enhances their skin penetration when used as a cosolvent with water (26,27,28).
Recently, Lam (29) has examined a series of propylene
glycol/water blends as potential vehicles for topical
preparations of benzocaine.

The role of Azone as percu-

taneous penetration enhancer for benzocaine solution in
60/40 propylene glycol/water was extensively investigated.
The in vitro skin penetration of benzocaine from a series
of dimethyl sulfoxide/water blends was also studied using
human cadaver skin.

These studies document penetration-

enhancing effects of propylene glycol, dimethylsulfoxide
and Azone primarily under conditions of decreasing thermodynamic activity.

Could benzocaine penetration flux be

further maximized by manipulating the concentration of
drug, solvent or the penetration accelerator?

Does the

enhancement of benzocaine penetration by Azone involve a
direct effect on the skin?

What is the contribution of

Azone as a solvent for benzocaine?
skin-vehicle partitioning?

How does it influence

These are some of the questions

that still need to be addressed.

r=r-.)1-
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Scope of the Present Study
This study was designed to help answer some of the
aforementioned questions and further refine the formulation
parameters for a topical preparation of benzocaine.

In

vitro skin penetration of benzocaine will be examined
under conditions of constant thermodynamic activity with
respect to penetrant benzocaine from 20/80 propylene glycol/
water and dimethyl sulfoxide/water systems.

The scope of

Azone as a penetration accelerator will be further scrutinized to define its appropriate level of concentration in
the vehicle and to shed more light on its mode of action
as a penetration enhancer.

In view of recent reports, the

effect of 2-pyrrolidone on percutaneous penetration of
benzocaine will also be examined.

Fi---

EXPERIMENTAL
J'.1aterials
~

Benzocaine,

1

propylene glycol

sulfoxide3 (DMSO), Azone,

4

9

(PG), dimethyl-

2-pyrrolidone 5 (2-P), kluce1 6

(hydroxypropyl cellulose), saline,
double distilled water.

2

7

absolute ethano1,

8

and

All chemicals were used as

received from the manufacturers.
Solubility Studies
The solubility of benzocaine in pure Azone was determined at 25° ± 0.5°C by magnetically stirring a known
excess amount of the drug in 5 ml Azone in a 10-ml glassstoppered Erlenmeyer flask for a period of 48 hours.

The

stirring was stopped and an aliquot of the supernatant was
filtered and appropriately diluted with ethanol.

The study

was done in duplicate and the concentration of benzocaine
was determined spectrophotometrically at 252 nm.

The

1 "Baker" Grade, Lot. 847340, J. T. Baker Chemical Co.,
Phillipsburg NJ.
2 USP Grade, Lot. 909349, J. T. Baker Chemical Co.,
Phillipsburg NJ.
· 3 "Baker Analysed" Lot. 805340, J .. T. Baker Chemical Co.,
Phillipsburg NJ.
4 Lot. 0157-132, Nelson Research, Irvine CA.
5 Lot. 713381, Fisher Scientific Comp., Fair Lawn NJ.
6 HF grade, Lot. 3027, Hercules Inc., Wilmington DE.
7 Sodium Chloride Injection USP, McGaw Lab., Irvine CA.
8 Ethyl Alcohol USP, Dl-19425, Gold Shield Chemical Corp.,
Hayward CA.
9 Univ. of the Pacific, Stockton CA.
11
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saturation solubility of the drug in Azone was obtained
from the standard curve pretested for compliance with
Beer's law.
The solubility of benzocaine in a series of DMSO/water
mixtures (40 to 80% in 20% increments) was determined
gravimetrically.

An excess of benzocaine was weighed and

added to 25 ml of DMSO/water mixtures in 50-ml glassstoppered Erlenmeyer flasks containing a Teflon-coated
magnetic stirring bar.

The solution was stirred for a

period of 48 hrs at 25° ± 0.5°.
settle.

Drug was allowed to

The supernatant was filtered, and a known volume

was placed in a preweighed 50-ml round bottom flask.
solvent was removed in vacuo

10

The

(rotatory evaporator) and

the flask was reweighed to a constant weight to calculate
the saturation solubility in each of these systems.

Each

determination was done in duplicate.
Preparation of Test Solutions,
Suspensions and Gels
All solutions were prepared on a volume/volume basis
unless indicated otherwise.

Excess amounts of benzocaine

were accurately weighed and carefully dispersed in the
following media:
a.

Propylene glycol in water (20 and 60% V/V)

b.

Dimethylsulfoxide in water (40, 60, and 80% V/V)

c.

2-Pyrrolidone in water (10, 20, 40, and 80% V/V)

10 Rotavapor R-110/RE-120, Duchi Lab.,

w.

Germany.

q-
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The dispersions of benzocaine in propylene glycol/water
(20/80) were gelled with 4% (W/V) hydroxypropyl cellulose,
after adding the proper concentration of Azone for the
purpose of testing for the effect of this adjuvant as a
skin penetration enhancer.
In Vitro Skin Penetration Studies
Skin Preparation:

Full thickness human abdominal skin

was obtained at autopsy and kept frozen until ready for
use.

Before the experiment, the skin was removed from the

freezer and allowed to thaw gradually at room temperature.
When the sample was pliable, it was placed epidermal side
down on a dissecting board.

All subcutaneous fat was then

carefully removed with a scalpel.

A section of .skin

derived fro~ a single subject yielded skin pieces for 8-10
diffusion cells.
Skin Diffusion Cell:
(Fig. 1).

The cell consists of two parts

The bottom part is a glass chamber with a sam-

pling port and is enclosed by a water jacket which allows
for circulation of water at selected temperature.
Teflon-coated magnetic stirring bar

11

A

was placed at the

bottom of the chamber to ensure good mixing.

The skin

piece was placed in position on an 0-ring between the two
ball joints of the top and bottom chambers, providing a
diffusion area of 2.01 sq. em.

11 Spinbar, V.W.R., San Francisco CA.

14

~~~~~;:---Top Chamber
+ltH~~~~o~~ Ring Groove

'------r---Skin

Outflow

Water Jacket

Figure 1.

Diagrammatic representation of the diffusion cell
used in penetration studies.

i-'i
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The top chamber was covered with parafilm and/or
plastic wrap during all penetration studies to provide
occlusion.

Normal saline (6.2 ml) was injected into the

12
.
.
1 ower c h amb er b y means o f a syr1nge
an d a p1ece
o f tu b.1ng.
Air bubbles that might be trapped on the dermal side of
the skin were allowed to escape via the sampling port by
carefully tilting the skin cell.
a magnetic stirrer.

Each cell was mounted on

The temperature of the receptor fluid

in the lower chamber was maintained at 37° ± 0.5° by circulating water from a constant-temperature water bath fitted
with a circulator pump.

13

The skin sample was allowed to

equilibrate in this condition overnight.

Before any formu-

lation was applied to the skin, the saline in the bottom
chamber was removed and replaced with fresh saline.

Approxi-

mately 2 ml of the test formulation was applied to the skin
surface in all cases.
All experiments were carried out for 12 hrs.

Samples

were withdrawn at appropriate time intervals and analyzed.
Pretreatment Studies:

Unless otherwise indicated,

all pretreatment studies involved surface application of
· the pure adjuvant on the excised human skin, mounted on
the skin cell, for a predetermined period of time.

Pieces

were then rinsed with ethanol followed by water and wiped
with a cotton swab to ensure complete removal of the excess

12 Norton Corp., Akron OH.
;L3 Haake Model-FE, v.~'iT.B. I San Francisco CA.

•

16
adjuvant prior to conducting drug penetration experiment.
'1--

Pretreatment by soaking involved total immersion of
the skin sample in the selected adjuvant for a predeter~

mined period of time followed by the removal of excess
adjuvant by successive rinsing with ethanol and water.

The

complete removal of excess adjuvant and water v-Jas ensured
by wiping with a cotton swab as before.
Assay Procedure
Analyses for benzocaine in the receptor fluid were
done on a spectrophotometer
through attachment.
rapid sampling.

14

fitted with a micro flow-

This allowed for small sample size and

The absorbance was recorded at 252 nm (29)

and converted into concentration by means of a standard
curve.

Beer's law was obeyed throughout the concentration

range studied (2.5 to 20.0 mcg/ml)

(see Appendix A and B).

Data Treatment
Each release experiment was performed in duplicate and
the average data were then used to draw the individual
graphs plotting the amount penetrated per unit area against
time.

Regression analyses were performed on all of these

plots to obtain penetration rates and other regression
parameters followed by testing for paralellism and calculating the 95% confidence limits for each slope.

14 Spectronic 710, Bauch and Lomb, Rochester NY.

-
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RESULTS
In these studies, in vitro penetration of benzocaine
across human cadaver skin has been examined from a series
of aqueous formulations primarily under conditions of maximum thermodynamic potential achieved by incorporating the
drug in excess of its solubility in respective vehicles.
The formulations included selected blends of Azone/PG/
water, DMSO/water, and 2-P/water.

The effects of Azone,

DMSO, and 2-P upon percutaneous penetration of benzocaine
were evaluated by either applying the appropriate formulation directly to the skin or by pretreating the skin with
pure adjuvant.

Since Azone is immiscible in aqueo'lS sys-

terns, various Azone/PG/water blends were gelled with 4%
hydroxypropyl cellulose to achieve uniform dispersion.
The following pages document the solubility and penetration data generated during the course of this investigation and also provide an analysis and interpretation of
these results.
Solubility Studies
The solubilities of benzocaine in 40, 60, and 80 percent
DMSO/water at 25° ± 0.5° are shown in Table I.
The solubility of benzocaine in PG/water systems has
been previously shown (29)

to have a range of 2.00 mg/ml in

water to 123.75 mg/ml in pure propylene glycol.

17
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TABLE I
Solubility of Benzocaine in DMSO/Water Mixtures
at 25° ± 0.5°

DMSO/Water

Solubility (mg/ml)

(% V /V)

-

Percentage
Solubility

80/20

533.00

53.3

60/40

68.60

6.86

40/60

2.51

0.25
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solubility of benzocaine in 20% and 60% propylene glycol
in water (vehicles used during this study) was found to
be 4.25 and 17 mg/ml respectively.
The solubility of benzocaine in Azone at 25° ± 0.5°
was found to be 254.17 mg/ml in sharp contrast to its
solubility of 4.25 mg/ml in 20% PG/water.
Penetration Studies
Unless otherwise indicated, all penetration studies
were conducted in duplicate and initiated using a known
excess of the drug in the vehicle.

The penetration data

obtained from all studies were tabulated and analyzed by
plotting the mean amount penetrated per unit area
against time (T).

(Q)

The regression analyses of the plots

were performed and 95% confidence limits of the steadystate regions of the penetration curve were established
using a programmable calculator.

15

The regression lines

were extrapolated to the time axis to determine the
intercepts.
In order to overcome the variation due to skin samples
from different donors and to effectively compare the results
of various experiments, a standard control containing
20 mg/ml of benzocaine in 20/80 PG/water was included in
all major experiments.

The observed steady-state fluxes
2

of the control ranged from a low of 25.17 meg/em /hr to a

15 TI Prograrnrnable 59, Texas Instruments, Dallas TX

;::
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2
2
high of 64.57 mcg/cm /hr with an average of 42.16 mcg/cm /

""!---~

hr.

This variation in flux values for the same control is

mostly attributable to the variability in human skin samples
from different donors and may be due to any number of factors such as skin age, skin condition, ethnic differences
and skin metabolism (8).

This variability has been con-

sidered in the design of all experiments.

--

DISCUSSION
To assure penetration of a drug from a vehicle, one
approach utilizes the differences in thermodynamic activities of the penetrant between the vehicle and the membrane
phases.

Ideally, such vehicles "push" the drug into the

skin without causing detectable injury to the skin membrane.
Intuitively one would choose a vehicle that results in a
relatively high thermodynamic activity of the active
ingredient in the formulation.

In the study by Lam (29)

this was accomplished by using a near-saturated solution
of benzocaine.

However, benzocaine concentration in the

applied vehicle suffered significant decline over the
duration of the experiment (12-24 hours), making it difficult to interpret the data.

This problem was overcome in

the present study by maintaining constant thermodynamic
flux in the donor vehicle with an excess of drug.
PG/Water System
The effect of benzocaine concentration on its penetration profiles from.20/80 PG/water is shown in Table II and
Figure 2.

Five different concentrations, covering a wide

range above and below the saturation solubility of the drug
in 20/80 PG/water system (4.25 mg/ml), were chosen to study
the effect of benzocaine concentration.

The steady state

fluxes were found to increase significantly with increasing

21
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TABLE II
The Penetration Pattern of Benzocaine from 20/80
PG/Water Gel as a Function of
Its Concentration

Benzocaine
Concentration
(mg/ml)

Flux
(Mcg/Cm2jHr)

Correlation
Coefficient
( r)

Intercept
(Hrs)

1

12.13 (±1.26)

0.992

-2.70

3

20.55 (±2.40)

0.990

-2.50

5

29.51 (±2.64)

0.994

-2.02

10

36.61 (±2.46)

0.997

-1.42

-

~e:_.::.:.._::_:

-

--

..

=

20

37.23 (±1.29)

0.999

-0.29

Fluxes increased significantly with increasing drug
concentration from 1 to 10 mg/ml (P < 0.01).
There was no significant difference in the fluxes of 10
and 20 (P > 0.50).
The numbers in parentheses indicate 95% confidence limits
of the respective slope.
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The Penetration Pattern of Benzocaine from 20/80
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drug concentration up to 10 mg/ml.

At this point, doubling

the drug concentration did not cause a significant change
in its penetration rate.
Azone/PG/Water System
A preliminary study examined the penetration pattern
of benzocaine at concentration levels of 3, 5 and 10 mg/ml
in 20/80 PG/water gel containing 5% Azone (Table III,
Fig. 3).

Approximately 30% decline in the flux associated

with a drop in drug concentration from 5 to 3% in the
absence of Azone (Table II)
presence of 5% Azone.

is completely reversed in the

The fluxes for both 3 and 5% benzo-

caine were almost equal.

The presence of Azone in the

formulation, at a benzocaine level below its saturation
solubility in the vehicle, apparently helped to overcome
the thermodynamic deficit resulting from very low drug
concentration, therefore enhancing the penetration through
the skin.
On the basis of Lam's work (29), three Azone concentrations (1, 5 and 10%) were chosen for the penetration
study conducted at the benzocaine concentration of 20 mg/
ml.

As can be seen From Table IV and Fig. 4, a statis-

tically significant increase in the flux (P < 0.05) relative to control resulted from applying the system containing
1% Azone.

The delivery systems containing 5% and 10% Azone

did not significantly enhance the cutaneous penetration of

Iii
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TABLE III
The Penetration Pattern of Benzocaine from PG/Water
20/80 Gel Containing 5% V/V Azone

Benzocaine
Concentration
(mg/ml)

3
5

10

Correlation
Coefficient
(r)

Intercept
(Hrs)

0.991

-3.27

(±0.95)

0.993

-2.70

12.80 (±0.67)

0.998

-2.32

Flux
(Mcg/Cm2 /Hr)

10.21 (±1.14)
9.94

The flux from 3 mg/ml drug level showed no significant
different as compared to that of 5 mg/ml level (P > 0.20).
There was a significant difference in the fluxes of 5 and
10 mg/ml level (P < 0.01).
The numbers in parentheses indicate 95% confidence limits
of the respective slope.
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TABLE IV
Effect of Azone Concentration on Percutaneous Penetration
of Benzocaine from 20/80 PG/Water at
Drug Level of 20 mg/ml

Azone
Concentration
Flux
(% V/V)
(Mcg/Cm2 /Hr)

Relative
Rate

Correlation
Coefficient Intercept
( r)
(Hrs)

10

26.60 (±1.80)

l. 06

0.995

-l. 86

5

26.25 (±1.44)

l. 04

0.997

-1.61

--

1

28.17 (±l. 62)

1.12

0.996

-l. 42

~-~=---

--

~--

~-

Con trol-l

25.17 (±1.21)

1

0.997

-l. 82

=-

Control-1 = 20 mg/ml benzocaine suspension in 20/80
PG/water gel.
The fluxes obtained from systems containing 5 and 10% Azone
showed no significant difference as compared to control
(P > 0.10) but flux from system containing 1% Azone was
significantly different from that of control (P < 0.05).
The numbers in parentheses indicate 95% confidence limits
of the respective slope.
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benzocaine.

When the experiment was repeated under iden;:=;-

tical conditions at benzocaine concentration level of
10 mg/ml, the drug penetration rate from the vehicle with
1% Azone was approximately the same as the control; however,
benzocaine flux was found to decrease significantly (P <
0.01) with increasing Azone concentration (Table V, Fig. 5).
In yet another study under similar conditions

(Table VI,

Fig. 6), when initial benzocaine concentration of the four
formulations

(including control) was adjusted to twice the

respective total solubility, the corresponding fluxes from
the formulations containing 1 and 10% Azone were significantly greater (P < 0.01) than that of the control.

The

flux from the vehicle containing 5% Azone was very significantly different (higher)

(P < 0. 001) from the control

value and was also higher than the flux value for vehicle
with 10% Azone.

These data reveal that skin penetration

enhancement effects of Azone are a function of its concentration and there appears to be an optimum Azone level for
obtaining maximum flux.

The relative magnitude of the

fluxes from the formulations containing 1, 5 and 10% Azone
relative to control in each study can be explained by
considering total drug concentration in each formulation
in relation to its saturation solubility in the vehicle and
taking into account that the solubility of benzocaine in
Azone is approximately 60 times that in 20/80 PG/water,
indicating a high affinity for benzocaine.

Based upon the
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TABLE V
Effect of Azone Concentration on Percutaneous Penetration
of Benzocaine from 20/80 PG/Water Gel at
Drug Level of 10 mg/ml

Azone
Concentration
Flux
(% V/V)
(Mcg/Cm2/Hr)

Relative
Rate

Correlation
Coefficient Intercept
(r)
(Hrs)

10

10.13 (±LOS)

0.45

0.992

-3.06

5

12.80 (±0.67)

0.57

0.998

-2.32

1

22.96 (±1.12)

1. 02

0.998

-0.84

22.42

1

0.997

-0.99

Con trol-l

(±1.46)

Control-1 = 10 mg/ml benzocaine suspension in 20/80 PG/
water gel with no Azone.
Fluxes decreased significantly with increasing Azone
concentration (P < 0.01).
There was no significant difference between the rates of
control and 1% (P > 0.20).
The numbers in parentheses indicate 95% confidence limits
of the respective slope.
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TABLE VI
Effect of Azone Concentration on Percutaneous Penetration of Benzocaine
from 20/80 PG/Water Gels

Azone
Concentration
(% V /V)

Benzocaine
Concentration
(mg/ml)

Flux
(Mcg/Cm2/Hr

Relative
Rate

Correlation
Coefficient
( r)

Intercept
(Hrs)

10

60

21.15 (±1.97)

1.22

0.991

-6.93

5

35

24.91 (±2.01)

1.44

0.994

-7.24

1

15

22.24 (±2.07)

1. 28

0.991

-6.08

Con trol-l

10

17.36 (±1.85)

1

0.989

-2.38

Cantral-l = PG/water 20/80 gel containing 10 mg/ml drug.
Concentration of benzocaine in each system was double the saturation solubility.
The fluxes obtained from systems containing 1 and 10% Azone showed a highly significant
difference from control (P < 0.01) and that from the system containing 5% Azone showed a
very highly significant difference from that of control (P < 0.001).
The numbers in parentheses indicate 95% confidence limits of the respective slope.
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solubility data, the saturation solubilities of benzocaine
in the 20/80 PG/water formulations containing 1, 5 and 10%
Azone were calculated to be 6.7, 16.5 and 29 mg/ml, respectively.

The data for 10% Azone in Table IV suggest that

drug depletion might have masked the penetration enhancement
effect of Azone since the actual drug level of 20 mg/ml
was well below the saturation level of 29 mg/ml.

The plots

of Figure 4 showing essentially a straight-line release
over 12-hour duration negate this possibility.

However,

drug depletion effects do appear to contribute to the
decline in flux when the drug concentration is cut in half
to 10 mg/ml (Table V, Fig. 5).

It is significant to note

that flux declined when Azone concentration was increased
from 5 to 10% even under conditions of constant thermodynamic potential (Table VI, Fig. 6).

Collectively, the

aforementioned observations lend strong support to the
conclusion that benzocaine has a high degree of affinity
for Azone and (at high levels of Azone) any penetration
enhancement effects are strongly negated by a corresponding
decrease in the skin/vehicle partition coefficient.

Among

the Azone concentrations investigated, 5% Azone generates
maximum flux under conditions of constant thermodynamic
activity of benzocaine in 20/80 PG/water gels.

This work

confirms the earlier findings of Lam (29) with respect to
penetration effects of Azone on benzocaine incorporated in
60/40 PG/water gels at near-saturation level.
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Effect of Azone Pretreatment
of Human Cadaver Skin
This set of experiments was conducted to determine if
the observed penetration enhancement effects of Azone were
in part or whole due to any direct effects on the skin
tissues.

The basic strategy involved pretreating the

excised human cadaver skin with neat Azone either by surface
application or soaking prior to use in the drug penetration
experiments.

The surface treatment involved application

of neat Azone to the epidermal surface of the skin mounted
on the diffusion cell or soaking the skin sample in the
neat Azone for an hour.

In either case, after the removal

of excess Azone, the skin was washed with ethanol followed
by water and surface dried.
then monitored.

The penetration profiles were

Two control preparations, with and without

Azone, were used in these studies.
The penetration profiles of benzocaine following
surface application of neat Azone for one, thirty and sixty
minutes revealed that fluxes from the pretreated samples
were significantly greater than either control (Table VII,
Fig. 7) and were independent of the duration of exposure
with the penetration enhancer.

The results were similar

when the presoaked and surface-treated samples were cornpared (Table VIII, Fig. 8).

Together, these pretreatment

studies reveal that Azone facilitates penetration of benzocaine molecules across human skin by directly reducing the
barrier effect of stratum corneum.

The water-rich dermal
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TABLE VII
Effect of Azone Pretreatment (Surface) on Percutaneous
Penetration of Benzocaine from 20/80
PG/Water Gel

Skin
Condition
1-min
pretreatment
30-min
pretreatment

Flux
(Mcg/Cm2/Hr)

Relative
Rate

40.19 (±4. 29)

l. 32

Correlation
Coefficient Intercept
( r)
(Hrs)

0.989

-1.61
--

43.12 (±3.51)

l. 41

0.995

-1.51
::::--=-=
~

1-hr
pretreatment

---

--

~~

41.67

(±3.56)

l . 37

0.995

-1.82

Contro1a

30.51 (±1.19)

1

0.999

-0.99

Contro1b

34.40 (±4.01)

1.13

0.990

-2.44

~

...

~

Drug concentration in all preparations was 20 mg/ml.
aControl - No pretreatment.·
bcontrol - No pretreatment.

5% Azone in the preparation.

The fluxes from pretreated skin were significantly different
from controls (P < 0.01).
The numbers in parentheses indicate 95% confidence limits of
the respective slope.
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TABLE VIII
Effect of Azone Pretreatment (Soaking Versus Surface
Application) on Percutaneous Penetration of
Benzocaine from 20/80 PG/Water Gel

Correlation
Coefficient

Intercept
(Hrs)

Skin
Condition

Flux
(Mcg/Cm2jHr)

Relative
Rate

Soaking

76.55 (±2.69)

1.19

0.999

-0.42

77.58 (±2.19)

1. 25

0.999

-1.00

64.57 (±2.08)

1

0.999

-1.07

61.88 (±3.82)

0.96

0.999

-1.35

Surface
Application
Control

1

Control 2

( r)

Benzocaine concentration in all preparations was 20 mg/ml.
Control
Azone.
Control
Azone.

1
2

No pretreatment.

20/80 PG/Water gel without

-No pretreatment.

20/80 PG/Water gel with 5%

The fluxes from pretreated skin were significantly higher
than controls (P < 0.01).
The numbers in parentheses indicate 95% confidence limits
of the respective slope.
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tissues do not appear to be involved.

The barrier-lowering

;::=;--""'

effect on the skin appears to be the primary component of
the overall mechanism of penetration enhancement by Azone.
;::::;---

Effect of DMSO on the In-Vitro
Percutaneous Penetration of
Benzocaine
This study was designed to complement the work done
earlier in our laboratory on the effects of DMSO on percutaneous absorption of benzocaine.

The previous study (29)

suggested that DMSO/water systems did not enhance the penetration of benzocaine into the stratum corneum when compared to the control of 60/40 propylene glycol/water.

This

was attributed in part to the drug depletion effects, and
the increased solubility of benzocaine in DMSO/water system
and consequent decrease in partitioning of benzocaine into
the receptor skin.
The present study, conducted under the conditions of
constant thermodynamic flux, suggested that DMSO significantly enhanced the penetration of benzocaine into the skin
as compared to control (Table IX, Fig. 9).

The steady-

state fluxes were significantly increased with increasing
DMSO concentration (P < 0.01).

The DMSO-induced enhance-

ment of penetration was observed over 40-80% range of
concentration of DMSO in the vehicle relative to 60/40 PG/
water control, also confirming that the lack of enhancement
reported by Lam (29) was indeed due to drug depletion.
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TABLE IX
Penetration of Benzocaine from DMSO/Water Systems
Through Full Thickness Human Skin

DMSO/Water
System
(V/V)

Flux
(Mcg/Cm2/Hr)

Relative
Rate

Correlation
Coefficient
(r)

Intercept
(Hrs)

80/20

49.52

(±5.25)

1. 62

0.990

0.95

60/40

42.87 (±3.22)

1.40

0.995

0.78

40/60

40.16

(±3.66)

1. 31

0.993

0.35

1

0.998

0.44

Control

30.60 (±1. 57)

~

-

Control

=

PG/water 60/40.

Concentration of benzocaine in all systems was above saturation throughout the duration of the experiment.
The fluxes of all DMSO/Water curves were significantly
different from control (P < 0.01).
The numbers in parentheses indicate 95% confidence limits
of the respective slope.

i

44

500

,...,r=j--

400

-e

N

300

u
.....

'0.0

u

e

0

200
E

---.-·-

~~
-

I0 0

0

4

8

12

Time (hrs)

Figure 9.

Penetration of Benzocaine from DMSO/Water Systems
Through Full Thickness Human Skin. Q versus t
plot.
Key:

DMSO/water (V/V)
• Control

0 40/60

D 80/20

• 60/40

i5

45
Earlier reports (18,19,33) have suggested that DMSO concentration must be between 60 to 90% in order to see penetration enhancing effects.
Exposure of skin to pure DMSO (surface pretreatment)
for one hour resulted in a significant increase in the
penetration rate of benzocaine over controls a and c
0.01) as shown in Table X, Figs. lOa and lOb.

(P <

This sug-

gested that observed penetration enhancement might be due
to a direct effect of the solvent on the stratum corneum.
The pretreatment of the skin with DMSO resulted in an
increase of approximately 50% in the total amount penetrated per unit area in the initial hour relative to
control-1, declining to approximately 42% after six hours,
then to only 20% after twelve hours.

Apparently DMSO

exerts a significant but temporary effect on the epidermal
barrier.

The effect lasts while the DMSO is held in the

stratum corneum and then as it is absorbed or washed out,
barrier function returns.
The effect of duration of exposure to DMSO was not
investigated during this study.
Effect of 2-Pyrrolidone on the
Percutaneous Penetration of
Benzocaine
The effect of 2-pyrrolidone on the percutaneous penetration of benzocaine is summarized in Table XI, Fig. 11.
The study was done using different mixtures of 2-pyrrolidone

~-
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TABLE X
~-

Percutaneous Penetration of Benzocaine Through
DMSO-Pretreated Skin

System
Identification

Flux
(Mcg/Cm2 /Hr)

Correlation
Coefficient
(r)

DMSO
Pretreatment

34.94 (±1.00)

0.999

-1.33

(±2.30)

0.994

-0.58

34.48 (±1.94)

0.997

-0.22

Control

a

Controlb

29.48

Intercept
(Hrs)

E
~--

-~-

Controlc

27.70 (±1.56)

0.997

-1.03

aB
.
. enzocalne
suspension in PG/Water 60/40.
bB enzocalne
.
suspension in PG/Water 20/80.
CB enzocalne
.
suspension in water.
pretreatment.

It was applied after

The fluxes through pretreated skin were significantly
different from those of controls a and c (P < 0.01).
The numbers in parentheses indicate 95% confidence limits
of the respective slope.
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Percutaneous Penetration of Benzocaine Through
DMSO-Pretreated Skin. Q versus t plot.
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TABLE XI
Effect of 2-Pyrrolidone Concentration on Percutaneous
Penetration of Benzocaine Through Full Thickness
Human Skin

Pyrrolidone/
Flux
Water System
(% V/V)
(Mcg/Cm2/Hr)

Relative
Rate

Correlation
Coefficient
( r)

Intercept
(Hrs)

10

38.75 (±1.63)

0.69

0.999

-0.84

20

41.14

(±2.22)

0.73

0.998

-0.62

40

52.35 (±2.81)

0.93

0.998

-0.57

~~
H--

80

66.12 (±6.01)

1.18

0.994

-1.47

~::::
5-~
~

Con trol-l

56.05 (±0.68)

1

0.999

-0.62

Prea
treatment

51.67 (±3.04)

0.92

0.997

0.59

Control-1

=

20 mg/ml drug in PG/Water 20/80 suspension.

Fluxes increased significantly as pyrrolidone concentrations
increased (P < 0.01).
Pretreatment showed no significant enhancement of penetration over control.
The numbers in parentheses indicate 95% confidence limits of
the respective slope.
aThe skin was surface-pretreated with neat 2-P for one hour.
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Effect of 2-Pyrrolidone Concentration on
Percutaneous Penetration of Benzocaine Through
Full Thickness Human Skin. Q versus t plot.
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in water (10, 20, 40 and 80% V/V)

to study its

concen~

tration effect on benzocaine penetration and to also see if
the observed enhancement, if any, was due to direct effect
on the stratum corneum.

The constant thermodynamic activity

in the donor vehicle was ensured by adding drug in excess
of the solubility in each vehicle.
As can be seen from the results, the steady-state
fluxes increased significantly (P < 0.01) with increasing
pyrrolidone concentration.

However, 2-pyrrolidone showed

measurable enhancement over the control only at 80% V/V
concentration.

Furthermore, pretreatment of the skin with

2-pyrrolidone by surface application for an hour produced
no significant enhancement of benzocaine penetration over
the control.

Berry (24) has shown that 2-pyrrolidone

behaves similarly to the aprotic solvent DMSO in the
presence of small polar penetrants such as methanoli however, its effect on larger, more complex semi-polar or
nonpolar molecules may not be easy to delineate.

In the

same study, the permeability coefficient, stratum corneum/
vehicle partition coefficient and diffusion coefficient of
both caffeine and octanol were shown to decrease in the
presence of 2-pyrrolidone.

The moderate enhancement of

benzocaine penetration observed in this study in the
presence of 80% 2-pyrrolidone in water could be due to
decrease in diffusional resistance of the stratum corneum
brought on by a slow interaction with stratum corneum.
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Additional studies including 2-pyrrolidone pretreatment,
covering longer duration of exposure to the solvent, are
needed in order to fully understand 2-pyrrolidone effect
on percutaneous penetration of benzocaine and to draw
meaningful conclusions.

SUMMARY AND CONCLUSION
The reported lack of efficacy of many OTC products
containing benzocaine during clinical use has encouraged
continuing efforts towards improving the percutaneous
penetration of benzocaine.

The present study combined the

thermodynamic approach with the incorporation of various
adjuvants in an attempt to maximize the in vitro percutaneous penetration of benzocaine.

The strategy involved

formulating each vehicle so as to sustain the optimum
thermodynamic potential of the drug across the donor vehicle
and receptor skin over a long period while maintaining a
;:;-

relatively high rate of drug transfer.

The role of the

so-called "penetration enhancers" Azone and dimethylsulfoxide was investigated in this context.

2-Pyrrolidone

was also briefly examined in view of the recent encouraging
reports (24,25).
Azone demonstrated a concentration-dependent enhancement of benzocaine penetration through skin from Azone/
propylene glycol/water systems containing 1, 5 and 10%
Azone respectively.

At low drug levels (below saturation

solubility), the incorporation of Azone in the formulation
effectively compensated for the thermodynamic deficit.
high drug levels (drug in excess of solubility) 5% Azone
appeared to have the maximum effect on the steady-state
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fluxes from 20/80 PG/water system.

Pretreatment studies

demonstrated that penetration enhancement by Azone was
significant, long lasting and largely due to a direct
barrier-lowering effect on the stratum corneum.
is extremely soluble in Azone.

Benzocaine

It would appear that the

major penetration-enhancing effect of Azone is strongly
negated by a reduction in vehicle to skin partitioning due
to its high affinity for benzocaine.
Under the conditions of the experiment, dimethylsulfoxide enhanced the percutaneous penetration of

benzo~

caine through full-thickness human skin at a concentration
level of 40-80% in water.

Pretreatment studies suggested

that DMSO exerted a significant but temporary effect on the
skin barrier.
With 2-pyrrolidone, a significant enhancement over
control was seen only at a very high 2-P level (80%).

The

results of the pretreatment studies were not conclusive.
direct barrier-lowering effect on the skin, if present, is
relatively slow to take effect.

Further investigation is

warranted.
In general, the three penetration enhancers examined
have demonstrated significant penetration enhancement of
benzocaine across human cadaver skin; however, the effects
were not dramatic.

Benzocaine readily penetrated the

well-hydrated skin from the PG/water vehicle.

The incor-

poration of Azone into this system might not be the most

A
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effective way to take advantage of its considerable barrierlowering effect on stratum corneum, especially for hydrophobic drugs like benzocaine.

With molecules of much lower

intrinsic penetrability and high hydrophilicity, Azone
might produce dramatic effects.

The clinical potential for

benzocaine formulations containing DMSO would appear to be
limited due to its high concentration requirement and
consequent possibilities for side effects.

Although 2-P

did not show promise with benzocaine it deserves further
screening with a spectrum of drugs of different physical/
chemical characteristics in order to assess its full
potential as adjuvant in dermatologic formulations.

-
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APPENDIX A
Beer's Law Plot of Benzocaine in
Normal Saline
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APPENDIX B
Beer's Law Plot of Benzocaine
in Ethanol
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